What we cover
Northline provides editorial coverage and reference material — not medical care. Here is the scope of what the Brief tracks.
Policy & legality
We monitor federal scheduling, state-level research initiatives, regulatory announcements and the compliance questions that shape whether — and how — ibogaine can be studied or accessed in the United States. See our legal-status guide.
Safety standards
We explain the screening, cardiac monitoring, contraindication and informed-consent practices that separate responsible programs from unsafe ones, detailed in our safety guide.
Access & research pathways
We outline the two lawful routes — authorized research and licensed treatment abroad — and the logistics and costs of each, in treatment abroad and cost.
Reference & explainers
We maintain plain-language explainers on how protocols work and how outcomes are measured, cross-referencing authoritative sources so readers can verify for themselves — see the process and ibogaine for opioid addiction.